Global Prenatal, Maternal & Carrier Diagnostic Market Analysis & Forecast Report
The global prenatal and maternal diagnostic test market is assessed in this report with respect to:
- Fetal Ultrasound
- Prenatal MRI Screening
- Carrier Screening
- Maternal Serum Screening Tests
- Noninvasive Prenatal Tests (NIPTs) using cffDNA
- NIPTs by Product
- Prenatal Diagnostic Invasive Tests
- Newborn Screening for Genetic Diseases
- Newborn Screening Market by Technology
- Preimplantation Screening/Diagnosis (PGS/PGD)
SWOT and merger/acquisition analysis is also performed as is a comprehensive documentation of the legislation pertaining to newborn screening by geography and how clinical programs are implemented in developed and developing markets.
Emerging trends in associated markets are also analysed in order to give the reader a comprehensive overview of how prenatal and maternal diagnostic testing is affected by the following industries:
- Molecular Diagnostics Market
- Liquid Biopsy Market
- Personalized Medicine Diagnostics Market
- In vitro Diagnostics (IVD) Market
This is a comprehensive 390 page report strengthened with over 280 figures and tables. The GLOBAL PRENATAL, MATERNAL & SCREENING DIAGNOSTIC MARKET report by Kelly Scientific has a detailed overview of 114 companies in the market with specifics pertaining to financial and business strategy, current products on the market and pipeline products.
Key Questions Answered in This Report
- What are the major prenatal pregnancy complications?
- What are the major genetic diseases detected in fetuses?
- What are the appropriate technologies for the detection of aneuploidies, microdeletions, duplications, copy number variations/alterations and translocations?
- How far is genetic counseling important in educating pregnant women and healthcare professionals?
- What is the impact of recent advances in clinical genomics on genetic counseling?
- What different noninvasive and invasive prenatal screening tests are performed during a pregnancy?
- What are the detection rates, true positive rates and true negative rates for NIPTs?
- Currently, in which countries are NIPTs available?
- What is the cost of NIPTs region-wise?
- What is the uptake of conventional maternal serum tests, NIPTs and invasive diagnostic tests in the S.?
- What is the average cost of maternal serum screening, NIPTs, fetal ultrasound screening and invasive diagnostic tests in the S.?
- What strategies should be adopted for clinical implementation of NIPTs for all pregnancies?
- What is the “patient directed model” for integration of NIPTs into healthcare systems?
- How does the detection rate of NIPTs compare with the rates of conventional maternal serum screening tests?
- What are the genetic disorders detectable by different prenatal screening and diagnostic tests?
- What is the reliability of amniocentesis and CVS results?
- Is the future of invasive diagnostic tests uncertain?
- Do intact fetal cells in maternal blood have use in noninvasive prenatal diagnosis (NIPD)?
- What about the use of trophoblast cells obtained from the cervix in NIPD?
- How many genetic conditions are detected during newborn genetic screening in the S.?
- What is the status of newborn genetic screening in developed, developing and other countries?
- What are the differences between preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD)?
- What PGS/PGD testing products are currently available on the market?
- What advanced technologies are currently used in prenatal, newborn and PGD testing?
- What is the global market for fetal ultrasound screening?
- Who are the market leaders in fetal ultrasound systems?
- What is the global and regional market for prenatal screening by fetal MRI?
- What is the global and regional market for maternal screening tests?
- What is the global and regional market for NIPTs using cffDNA?
- What is the global and regional market for invasive prenatal diagnostic tests?
- What is the global and regional market for newborn screening tests?
- What is the global market for newborn screening tests by technology?
- What is the global and regional market for pre-implantation genetic diagnosis (PGD)?
- What is the global market for molecular diagnostics?
- What is the global market for liquid biopsy tests?
- What is the overall global market for personalized medicine diagnostics?
- What is the overall global market for in vitro diagnostics (IVD)?
- What are the recent acquisition activities in prenatal screening industry?
- What are the important factors that drive the growth of prenatal and newborn genetic testing industry?
- What are the challenges faced by the prenatal screening industry?
- What are the possible future developments in prenatal screening industry?
For more information, please email firstname.lastname@example.org
An updated version of this report will be available in 2021